Neutrophil gelatinase-associated lipocalin: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ *Neutrophil gelatinase-associated lipocalin (NGAL), from the family of lipocalins, is a polypeptide that is secreted following renal tubular cell injury.<ref na...") |
(No difference)
|
Revision as of 05:52, 1 July 2020
- Neutrophil gelatinase-associated lipocalin (NGAL), from the family of lipocalins, is a polypeptide that is secreted following renal tubular cell injury.[1] [2] [3]
- Elevated NGAL levels in the urine and plasma can be used as a useful biomarker for early diagnosis of AKI before creatinine rise or changes in urinary output.[3]
- NGAL level is correlated with the severity of AKI.[3]
References
- ↑ Devarajan P (2008). "Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease". Scand J Clin Lab Invest Suppl. 241: 89–94. doi:10.1080/00365510802150158. PMC 2528839. PMID 18569973.
- ↑ Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J; et al. (2003). "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury". J Am Soc Nephrol. 14 (10): 2534–43. doi:10.1097/01.asn.0000088027.54400.c6. PMID 14514731.
- ↑ 3.0 3.1 3.2 Shang W, Wang Z (2017). "The Update of NGAL in Acute Kidney Injury". Curr Protein Pept Sci. 18 (12): 1211–1217. doi:10.2174/1389203717666160909125004. PMID 27634444.